Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences ...
Kura Oncology is positioning ziftomenib (KOMZIFTI) as a combination backbone in AML, not just a relapsed/refractory ...
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted ...
As Bristol Myers Squibb attempts to convert two accelerated oncology nods for Krazati into traditional FDA approvals, the ...
BAKU, Azerbaijan, July 8. ASCO, a subsidiary of the AZCON holding company, held discussions with a delegation from the ...
Uzbekistan is planning to form a joint fleet with Azerbaijan on the Caspian Sea and establish a joint venture between JSC UTY CARGO, Uzbekistan's national multimodal cargo transportation company, and ...
This summer marks the 50th anniversary of one of the most bizarre disease outbreaks in the history of microbiology – and one ...
Under an FDA ruling that expands access to clinical trials, HonorHealth Research Institute is one of the first in the nation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results